Artificial Intelligence in Drug Development: Patent Considerations, PLI’s Developments in Pharmaceutical and Biotech Patent Law (Dec. 1, 2023)
December 01, 2023
Artificial Intelligence in Drug Development: Patent Considerations, PLI’s Developments in Pharmaceutical and Biotech Patent Law
This event has already occurred.
Related Insights
Amgen Plans At-Risk Launch of EYLEA® Biosimilar Pavblu™ After Federal Circuit Lifts Temporary Injunction
Amgen Plans At-Risk Launch of EYLEA® Biosimilar Pavblu™ After Federal Circuit Lifts Temporary Injunction
October 24, 2024
3min
Business Groups Rush to File Federal Court Challenges to the FTC’s Negative Option “Click-to-Cancel” Rule
Business Groups Rush to File Federal Court Challenges to the FTC’s Negative Option “Click-to-Cancel” Rule
October 24, 2024
2min
Labor and Employment Newsletter
Labor and Employment Newsletter
October 24, 2024
3min
Events
Attending Money 20/20?
Attending Money 20/20?
October 27 - 30, 2024 Las Vegas, NV
DOJ Forfeitures, Cooperation and Receiver Appointments
DOJ Forfeitures, Cooperation and Receiver Appointments
October 29, 2024 Santa Barbara, CA - National Association of Federal Equity Receivers (NAFER)
NAFER Annual Conference
NAFER Annual Conference
October 29, 2024 Santa Barbara, CA - National Association of Federal Equity Receivers (NAFER)